Amgen (AMGN)
Nasdaq
Amgen (AMGN) stock price, session move and chart. AMGN stock news and the latest available quote on NASDAQ.
Current Amgen forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About Amgen
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
From the companyAmgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer.
Company profile
Amgen executives and management
Congress trades in AMGN
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Sheldon Whitehouse Senate · Democrat | Sell | $1,001 - $15,000 | Aug 12, 2026 | Sep 2, 2026 |
Amgen stock research: financials and ownership
Amgen revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 2.16M |
| Shares Outstanding | 540.00M |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Amgen revenue by segment
Scroll here to load data.
Amgen revenue by region
Scroll here to load data.
Amgen stock margins
Scroll here to load data.
Amgen historical valuation
Scroll here to load data.
Amgen annual returns
Scroll here to load data.
Amgen financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
Related Articles & Updates
TechGraph News · 2026-10-18The Connected Exchange: NCDEX CTO Balkrishna Shankwalker on the Future of the Commodity Market
TechGraph News · 2026-10-15NumanCap Review 2026 | Markets, Margin and Mobile
TechGraph News · 2026-10-01What Does India’s First Tokenised Bond Pilot Mean for the Debt Market?
TechGraph News · 2026-09-15Javier Olivan Plans $1.04 Million Meta Share Sale
TechGraph News · 2026-09-13NVIDIA Awards 172,507 Shares to EVP Nicholas Parker
TechGraph News · 2026-09-13Meta CPO Chris Cox Sells Shares Worth $13 Mn
Amgen fair value
Scroll here to load data.
Amgen options chain
Scroll here to load data.
Amgen — frequently asked questions
What is the Amgen stock price?
The Amgen (AMGN) stock price is the live quote at the top of this page. Amgen trades on Nasdaq.
Where is the AMGN stock quote and news?
The AMGN stock quote, chart and news are on this page.
Where is Amgen listed?
Amgen trades as AMGN on Nasdaq.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.

